成纤维生长因子受体2在原发及复发成釉细胞瘤中的表达及意义

doi:10.19438/j.cjoms.2017.03.013

中国口腔颌面外科杂志 ›› 2017, Vol. 15 ›› Issue (3): 254-258.doi: 10.19438/j.cjoms.2017.03.013

成纤维生长因子受体2在原发及复发成釉细胞瘤中的表达及意义

唐渔，季彤

上海交通大学医学院附属第九人民医院·口腔医学院口腔颌面-头颈肿瘤科，上海市口腔医学重点实验室，上海 200011

收稿日期:2016-03-15 修回日期:2016-05-05 出版日期:2017-05-20 发布日期:2017-06-09
通讯作者: 国家自然科学基金（81671009）
作者简介:唐渔（1991-），女，硕士，E-mail:xiaoxiaoyuer925@163.com
基金资助:
季彤，E-mail: jitong70@hotmail.com

The relationship between fibroblast growth factor receptor type 2 and clinical characteristics of primary/recurrent ameloblastoma

TANG Yu, JI Tong.

Department of Oromaxillofacial Head and Neck Oncology, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine；Shanghai Key Laboratory of Stomatology. Shanghai 200011, China

Received:2016-03-15 Revised:2016-05-05 Online:2017-05-20 Published:2017-06-09

摘要/Abstract

摘要： 目的：检测成纤维细胞生长因子受体2（FGFR2）在颌骨原发及复发成釉细胞瘤中的表达，并探讨其与成釉细胞瘤临床特点尤其是侵袭和复发的关系。方法：选择手术切除的多囊型成釉细胞瘤患者64例共96例成釉细胞瘤组织，分为复发组（第1组，32例患者64例组织）和原发组（第2组，32例患者 32例组织），以10例正常牙囊组织为对照，采用免疫组织化学方法检测96例成釉细胞瘤组织及10例牙囊组织中FGFR2蛋白的表达。应用SAS9.3软件包分析FGFR2与成釉细胞瘤的关系。结果：96例成釉细胞瘤中均检测到FGFR2的表达，复发成釉细胞瘤组织中FGFR2的表达显著高于原发成釉细胞瘤；第1组中原发成釉细胞瘤的平均直径为4.02 cm，第2组中成釉细胞瘤的平均直径为3.1 cm（P<0.05）且最大直径为3.9 cm。上颌骨复发成釉细胞瘤中FGFR2的阳性率显著高于下颌骨复发成釉细胞瘤。结论：肿瘤复发与成釉细胞瘤的大小相关，直径大于3.9 cm的成釉细胞瘤较直径小于3.9 cm者更易复发，且复发成釉细胞瘤中FGFR2的阳性率显著高于原发成釉细胞瘤，表明FGFR2的表达与成釉细胞瘤的复发相关，可能是成釉细胞瘤局部复发的机制之一。

关键词: 颌骨, 原发成釉细胞瘤, 复发成釉细胞瘤, FGFR2

Abstract: PURPOSE: To detect the immunohistochemical expression of fibroblast growth factor receptor type 2 (FGFR2) in primary ameloblastoma and recurrent ameloblastoma, and to determine its role in development of ameloblastoma, especially in invasion and recurrence of ameloblastoma. METHODS: Ninety-six formalin-fixed, paraffin-embedded tissue blocks of ameloblastoma specimens from 32 patients who had two surgeries due to recurrence and 32 patients who had only one surgery were compared at protein expression level using immunohistochemistry for FGFR2 staining. Statistical analysis was performed by use of SAS 9.3 software package, to determine the relationship between the expression of FGFR2 and clinical parameters. RESULTS: FGFR2 immunostaining was evident in all specimens, the staining in recurrent ameloblastoma was significantly stronger than in primary ameloblastoma. Statistical analysis showed that FGFR2 expression was significantly higher in recurrent ameloblastoma than in primary ameloblastoma; FGFR2 expression was significantly higher in maxillary recurrent ameloblastoma than in mandibular recurrent ameloblastoma; patient with tumor size over 3.9 cm had a higher rate of recurrence. CONCLUSION: High expression of FGFR2 plays an important role in invasion and recurrence of ameloblastoma.

Key words: Jaw bone, Recurrent ameloblastoma, Primary ameloblastoma, FGFR2

中图分类号:

R739.8

唐渔，季彤. 成纤维生长因子受体2在原发及复发成釉细胞瘤中的表达及意义[J]. 中国口腔颌面外科杂志, 2017, 15(3): 254-258.

TANG Yu, JI Tong.. The relationship between fibroblast growth factor receptor type 2 and clinical characteristics of primary/recurrent ameloblastoma[J]. China J Oral Maxillofac Surg, 2017, 15(3): 254-258.

参考文献

[1] Almeida Rde A, Andrade ES, Barbalho JC, et al. Recurrence rate following treatment for primary multicystic ameloblastoma: systematic review and meta-analysis [J]. Int J Oral Maxillofac Surg, 2016, 45(3): 359-367.
[2] Rastogi V, Pandilwar PK, Maitra S. Ameloblastoma: an evidence based study [J]. J Maxillofac Oral Surg, 2010, 9(2): 173-177.
[3] Nakamura N, Higuchi Y, Mitsuyasu T, et al. Comparison of long-term results between different approaches to ameloblastoma [J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2002, 93(1): 13-20.
[4] Beenken A, Mohammadi M. The FGF family: biology, pathophysiology and therapy [J]. Nat Rev Drug Discov, 2009, 8(3): 235-253.
[5] Wilkie AO, Morriss-Kay GM, Jones EY, et al. Functions of fibroblast growth factors and their receptors [J]. Curr Biol,1995, 5(5):500-507.
[6] Cormier S, Leroy C, Delezoide AL, et al. Expression of fibroblast growth factors 18 and 23 during human embryonic and fetal development [J]. Gene Expr Patterns, 2005, 5(4): 569-573.
[7] Li X, Wang C, Xiao J, et al. Fibroblast growth factors, old kids on the new block [J]. Semin Cell Dev Biol, 2016, 53: 155-167.
[8] Kettunen P, Laurikkal J, It ranta P, et al. Association of FGF-3 and FGF-10 with signaling networks regulating tooth morphogenesis [J]. Dev Dyn, 2000, 219(3): 322-332
[9] Klein OD, Lyons DB, Balooch G, et al. An FGF signaling loop sustains the generation of differentiated progeny from stem cells in mouse incisors [J]. Development, 2008, 135(2): 377-385.
[10] Han N, Kim MA, Lee HS, et al. Evaluation of fibroblast growth factor receptor 2 expression, heterogeneity and clinical significance in gastric cancer [J]. Pathobiology, 2015, 82(6): 269-279.
[11] Liu K, Song X, Zhu M, et al. Overexpression of contributes to inherent resistance to MET inhibitors in MET-amplified patient-derived gastric cancer xenografts [J]. Oncol Lett, 2015, 10(4): 2003-2008.
[12] Mathur A, Ware C, Davis L, et al. FGFR2 is amplified in the NCI-H716 colorectal cancer cell line and is required for growth and survival [J]. PLoS One, 2014, 9(6): e98515.
[13] Meyer KB, Maia AT, O'Reilly M, et al. Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer [J]. PLoS Biol, 2008, 6(5): e108.
[14] Nomura S, Yoshitomi H, Takano S, et al. FGF10/FGFR2 signal induces cell migration and invasion in pancreatic cancer [J]. Br J Cancer, 2008, 99(2): 305-313.
[15] 李琳琳, 刘云鹏, 侯柯佐, 等. FGFR2和c-Cbl在胃癌组织中的表达及其临床意义 [J]. 中国癌症杂志, 2009, 19(8): 609-614.
[16] 覃山羽, 姜海行, 李信, 等. 胃癌及癌前病变中bFGF 、 FGFR-2及Hpa的表达及其意义[J]. 中国实用内科杂志, 2007, 27(17): 1379-1383.
[17] 郑永华, 牟一平, 张锐利, 等. 成纤维细胞生长因子2（FGFR2）在直肠癌中的表达意义[D]. 杭州: 浙江大学, 2011.
[18] Sato T, Oshima T, Yoshihara K, et al. Overexpression of the fibroblast growth factor receptor-1 gene correlates with liver metastasis in colorectal cancer[J]. Oncol Rep, 2009, 21(1): 211-216.
[19] Brown NA, Rolland D, McHugh JB, et al. Activating FGFR2-RAS-BRAF mutations in ameloblastoma [J]. Clin Cancer Res, 2014, 20(21): 5517-5526.
[20] Diniz MG, Gomes CC, Guimar es BV, et al. Assessment of BRAFV600E and SMOF412E mutations in epithelial odontogenic tumours [J]. Tumour Biol, 2015,36(7): 5649-5653.
[21] Nakao Y, Mitsuyasu T, Kawano S, et al. Fibroblast growth factors 7 and 10 are involved in ameloblastoma proliferation via the mitogen-activated protein kinase pathway [J]. Int J Oncol, 2013, 43(5): 1377-1384.
[22] Martin AJ, Grant A, Ashfield AM, et al. FGFR2 protein expression in breast cancer: nuclear localisation and correlation with patient genotype [J]. BMC Res Notes, 2011, 4: 72.
[23] Mcinerney N, Colleran G, Rowan A, et al. Low penetrance breast cancer predisposition SNPs are site specific [J]. Breast Cancer Res Treat, 2009, 117(1): 151-159.

成纤维生长因子受体2在原发及复发成釉细胞瘤中的表达及意义

The relationship between fibroblast growth factor receptor type 2 and clinical characteristics of primary/recurrent ameloblastoma

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	王菡韶, 魏文斌, 赵洪波, 张亚莹, 朱凌, 陈敏洁. 能谱CT单能量成像在颌骨骨髓炎病灶显示中的应用价值评价[J]. 中国口腔颌面外科杂志, 2024, 22(5): 435-439.
[2]	孙思敏, 张森林. 动态导航引导下下颌骨缺损腓骨瓣移植修复区种植体植入1例报告[J]. 中国口腔颌面外科杂志, 2024, 22(5): 513-517.
[3]	楚晨, 宗倩, 寻兴祥, 赵谦, 袁荣涛, 许晓. 温敏性bFGF/Dex脂质体-水凝胶复合支架的神经化骨再生评价[J]. 中国口腔颌面外科杂志, 2024, 22(4): 322-328.
[4]	袁露函, 楚晨, 袁荣涛. 高活性骨替代材料在颌面部骨组织工程中的应用进展[J]. 中国口腔颌面外科杂志, 2024, 22(4): 394-399.
[5]	孟宇翔, 宋凯, 何宗轩, 王琳, 葛胜优, 魏晨珂, 尚伟. 微血管吻合器在股前外侧皮瓣修复口腔恶性肿瘤术后缺损中的应用效果[J]. 中国口腔颌面外科杂志, 2024, 22(3): 268-273.
[6]	张冰清, 史敬存, 吴梓谦, 张于涵, 王婕妤, 肖孟, 王磊. 同期神经化腓骨瓣用于下颌骨重建及下唇感觉恢复的术式初探[J]. 中国口腔颌面外科杂志, 2024, 22(2): 143-147.
[7]	张强, 李庆, 张佳. 颌骨骨肉瘤25例影像与临床预后分析[J]. 中国口腔颌面外科杂志, 2024, 22(2): 186-191.
[8]	邓磊, 黄海涛, 张锐. 下颌后牙区牙源性透明细胞癌1例报告及文献复习[J]. 中国口腔颌面外科杂志, 2024, 22(2): 206-208.
[9]	王周阳, 凌霄, 施燕妮, 王磊, 秦兴军. ANO5非移码插入突变型GDD家系临床分析及其诱导多能干细胞的构建[J]. 中国口腔颌面外科杂志, 2024, 22(1): 16-22.
[10]	王周阳，凌霄，施燕妮，王磊，秦兴军. ANO5非移码插入突变型GDD家系临床分析及其诱导多能干细胞的构建[J]. 中国口腔颌面外科杂志, 2024, 22(1): 36-41.
[11]	林惠, 高云飞, 刘晶, 马旭辉. 槐角提取物对颌骨骨髓间充质干细胞成骨向分化的影响[J]. 中国口腔颌面外科杂志, 2024, 22(1): 73-77.
[12]	李晓, 王豪伟, 杨西涛, 王德明, 范新东, 苏立新. 颌骨骨内动静脉畸形介入栓塞治疗远期疗效分析[J]. 中国口腔颌面外科杂志, 2024, 22(1): 78-83.
[13]	汪涛, 谢福平, 陈嘉民, 刘欢欢, 吴烨. 数字化技术联合KSP-CDIO教学模式在下颌骨囊肿教学中的应用[J]. 中国口腔颌面外科杂志, 2023, 21(6): 593-597.
[14]	韩亚茹, 孙霞飞, 吴大铭. 下颌骨原发性异位脑膜瘤1例报告[J]. 中国口腔颌面外科杂志, 2023, 21(6): 630-632.
[15]	何悦, 陈珩, 安金刚, 郭玉兴, 潘剑, 田磊, 刘冰, 侯劲松, 李劲松, 蒋灿华, 李萌宇, 田臻, 许洁, 朱凌, 孙长伏, 郅克谦, 瞿晴, 宗春琳, 孙晶晶, 张志愿. 药物相关性颌骨坏死临床诊疗专家共识[J]. 中国口腔颌面外科杂志, 2023, 21(4): 313-325.